Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2003
10/30/2003WO2003020320A3 Nanoparticles comprising biologically active tnf which is immobilised on the same
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003004661A3 Adenovital vectors with cell type specificity for mesenchymal cells
10/30/2003WO2003004501A3 (hetero) aryl substituted benzofurans as 5-ht ligands
10/30/2003WO2002098919A3 Method for apo ciii measurement in apob and non apob containing particles
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003WO2002070741A3 Methods, systems and computer program products for determining the biological effect and/or activity of drugs, chemical substances and/or pharmaceutical compositions based on their effect on the methylation status of the dna
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002042303A3 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003WO2002032447A3 Cell damage inhibitor
10/30/2003WO2002026826A3 Proteins and nucleic acids encoding same
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003US20030204206 Electrically responsive promoter system
10/30/2003US20030204168 Coated vascular devices
10/30/2003US20030204093 Useful as a pharmaceutical either alone or in combination with amlodipine in treating angina and hypertension
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030204049 Which have affinity/targeting vector for integrin receptors; diagnostic imaging
10/30/2003US20030203973 Administering triethylenetetramine to lower copper value of myocardium; for treatment of diabetes
10/30/2003US20030203966 Such as N-(3,5-dimethyl-4-((nitromethyl)sulphonyl) phenyl)benzenesulphonamide for treatment/prevention of peripheral and autonomous neurolgical diabetic complications, renal and ocular disorders (cataracts, retinopathy)
10/30/2003US20030203965 Benzyl (S,S)-2-(2-acetylsulphanylmethyl-3-benzo(1,3)dioxol-5-ylpropionyl -amino)propionate; differential scanning calorimetry; for treatment of hypertension/cardiovascular system disorders
10/30/2003US20030203958 Therapeutic inhibitor of vascular smooth muscle cells
10/30/2003US20030203957 Selected fused pyrrolocarbazoles
10/30/2003US20030203953 Repinotan kit
10/30/2003US20030203947 Activator of PPAR delta
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
10/30/2003US20030203927 Thrombin receptor antagonists
10/30/2003US20030203926 For treatment of inflammatory or autoimmune condition, viral infection, cancer
10/30/2003US20030203922 Substituted amine derivatives and methods of use
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203913 Beta3 adrenergic receptor agonists and uses thereof
10/30/2003US20030203905 Inhibitors of p38
10/30/2003US20030203898 Therapeutic treatment and/or prophylaxis of arteriosclerosis and hypercholesterolaemia
10/30/2003US20030203896 Novel guanidino derivatives as inhibitors of cell adhesion
10/30/2003US20030203893 Benzimidazole derivatives, preparation and therapeutic use thereof
10/30/2003US20030203892 A synergistic therapeutic treatment for hypercholesterolemic condition
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203855 17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
10/30/2003US20030203854 Composition for effecting serum cholesterol levels
10/30/2003US20030203842 Apolipoprotein A-l agonists and their use to treat dyslipidemic disorders
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203373 Method for identifying a pharmacologically active substance
10/30/2003US20030203057 A mixture of isoflavones or isoflavone glycosides, pungent, bitter and sour substances and/or scymnol and scymnol esters; secretion of biogenic monoamines; antidepressants; seasonal affective disorder; Alzheimer's disease and much more!
10/30/2003US20030203055 Administering a selective norepinephrine norepinephrine-serotonin reuptake inhibitor, e.g., milnacipran, that is not a tricylcic antidepressant; gastrointestinal and urogenital disorders; analgesics
10/30/2003US20030203053 Method and composition for improving sexual fitness
10/30/2003US20030203030 Polymeric gel delivery system for pharmaceuticals
10/30/2003US20030203013 Microbial cellulose wound dressing for treating chronic wounds
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202969 Enhancing therapeutic effectiveness of nitric oxide inhalation
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003US20030202959 Polymeric acyl derivatives of indoles
10/30/2003EP1496982A2 Solid forms of salts with tyrosine kinase activity
10/30/2003CA2770411A1 Aerosol containing a particulate active substance
10/30/2003CA2483010A1 Placental derived stem cells and uses thereof
10/30/2003CA2482991A1 Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof
10/30/2003CA2482928A1 Method of treating arrhythmias comprising administration of an a1 adenosine agonist with a beta blocker, calcium channel blocker or a cardiac glycoside
10/30/2003CA2482919A1 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
10/30/2003CA2482714A1 Indane acetic acid derivatives and their use as pharmaceutical agents
10/30/2003CA2482591A1 Combination therapy for the treatment of cancer
10/30/2003CA2482464A1 Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
10/30/2003CA2482260A1 Use of heme oxygenase-1 and products of heme degradation
10/30/2003CA2482147A1 Medicament for therapeutic treatment of vascular disease
10/30/2003CA2482022A1 Novel compounds
10/30/2003CA2481940A1 (1-4-piperidinyl) benzimidazole derivatives useful as histamine h3 antagonists
10/30/2003CA2481753A1 Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
10/30/2003CA2481749A1 Pharmaceutical composition comprising an alpha-ketoalkanoic acid ester or -amide and lactic acid or a lactic acid salt
10/30/2003CA2480325A1 Solid forms of salts with tyrosine kinase activity
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357115A1 Alkanoic acid derivatives, process for their production and use thereof
10/29/2003EP1356817A1 Therapeutic and/or preventive agents for diseases due to retinal ischemia
10/29/2003EP1356816A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient
10/29/2003EP1356815A1 Analgesic and antiinflammatory drugs
10/29/2003EP1356288A1 Screening assay for cotranslational translocation interfering compounds
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356058A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356042A2 Carbohydrate-associated proteins
10/29/2003EP1356032A2 Human kinases
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1356024A2 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
10/29/2003EP1355945A2 Flint glycoforms
10/29/2003EP1355943A2 Neurotransmitter transporters
10/29/2003EP1355940A2 Urotensin-ii agonists and antagonists
10/29/2003EP1355937A2 Mammalian alpha-helical protein-53
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355935A2 Secreted proteins
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355909A2 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/29/2003EP1355908A1 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them
10/29/2003EP1355907A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
10/29/2003EP1355905A1 Pyrazole compounds useful as protein kinase inhibitors
1 ... 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 ... 1595